Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our top-notch dedicated system is used to design specialised libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
This process includes extensive molecular simulations of the receptor in its native membrane environment, along with ensemble virtual screening that accounts for its conformational mobility. In the case of dimeric or oligomeric receptors, the entire functional complex is modelled, identifying potential binding pockets on and between the subunits to encompass all possible mechanisms of action.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q92633
UPID:
LPAR1_HUMAN
Alternative names:
Lysophosphatidic acid receptor Edg-2
Alternative UPACC:
Q92633; B4DK36; O00656; O00722; P78351
Background:
Lysophosphatidic acid receptor 1 (LPA1), also known as Edg-2, is a crucial receptor for lysophosphatidic acid (LPA). It plays a pivotal role in actin cytoskeleton reorganization, cell migration, differentiation, and proliferation. LPA1 activation triggers multiple signaling pathways, including G(i)/G(o), G(12)/G(13), and G(q) families, leading to various cellular responses such as decreased cAMP levels, increased cytoplasmic Ca(2+) levels, and activation of MAP kinases. It is essential for normal brain development, skeleton development, and the regulation of cell shape.
Therapeutic significance:
Understanding the role of Lysophosphatidic acid receptor 1 could open doors to potential therapeutic strategies.